Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,441 to 1,460 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies. | Front Physiol | 2020 | 32581851 | PubTator, text mining | PubMed |
| Common neurodegenerative disorders in the perioperative setting: Recommendations for screening from the Society for Perioperative Assessment and Quality Improvement (SPAQI). | Perioper Care Oper Room Manag | 2020 | 32577538 | PubTator, text mining | PubMed |
| Immunoadsorption for Treatment of Patients with Suspected Alzheimer Dementia and Agonistic Autoantibodies against Alpha1a-Adrenoceptor-Rationale and Design of the IMAD Pilot Study. | J Clin Med | 2020 | 32575439 | PubTator, text mining | PubMed |
| Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology. | Mol Genet Genomic Med | 2020 | 32573981 | PubTator, text mining | PubMed |
| Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity. | Blood | 2020 | 32573723 | PubTator, text mining | PubMed |
| Comparative proteomics analysis of plasma protein in patients with neuropsychiatric systemic lupus erythematosus. | Ann Transl Med | 2020 | 32566606 | PubTator, text mining | PubMed |
| Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach. | PeerJ | 2020 | 32566414 | PubTator, text mining | PubMed |
| Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. | Mol Cell | 2020 | 32559423 | PubTator, text mining | PubMed |
| Cytochrome P4501B1 in bone marrow is co-expressed with key markers of mesenchymal stem cells. BMS2 cell line models PAH disruption of bone marrow niche development functions. | Toxicol Appl Pharmacol | 2020 | 32553695 | PubTator, text mining | PubMed |
| Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer. | Int J Mol Sci | 2020 | 32545874 | PubTator, text mining | PubMed |
| Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations. | Commun Biol | 2020 | 32533056 | PubTator, text mining | PubMed |
| Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment. | Front Oncol | 2020 | 32528879 | PubTator, text mining | PubMed |
| Prenatal exposure to bisphenol A alters the transcriptome-interactome profiles of genes associated with Alzheimer's disease in the offspring hippocampus. | Sci Rep | 2020 | 32528016 | PubTator, text mining | PubMed |
| Invasive species versus pollutants: Potential of Limnoperna fortunei to degrade glyphosate-based commercial formulations. | Ecotoxicol Environ Saf | 2020 | 32526590 | PubTator, text mining | PubMed |
| Integrated Proteomics and Metabolomics Reveal the Mechanism of Nephrotoxicity Induced by Triptolide. | Chem Res Toxicol | 2020 | 32519852 | PubTator, text mining | PubMed |
| Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology. | Alzheimers Res Ther | 2020 | 32517787 | PubTator, text mining | PubMed |
| Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma. | Cancer Lett | 2020 | 32512023 | PubTator, text mining | PubMed |
| Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy. | Front Oncol | 2020 | 32509584 | PubTator, text mining | PubMed |
| Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis. | Front Cell Neurosci | 2020 | 32508595 | PubTator, text mining | PubMed |
| The Molecular Link from Diet to Cancer Cell Metabolism. | Mol Cell | 2020 | 32504556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=73